IFNA1 and neoplasm: Interestingly, CHIP-WT-expressing A549 tumors in combination with IFN-α led to complete tumor regression in two out of the four mice, whereas no complete regression was observed in the CHIP-4KR plus IFN-α group (Fig. 7b).